Patent · US Active

CD95-Fc fusion proteins

US8007813B2 · kind B2 · utility

6Cited by
1References
14Claims
0Family size

Assignees

Inventor

Key dates

Filing dateMar 26, 2004
Grant dateAug 30, 2011
Priority date—
Expiry dateMar 30, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to fusion proteins comprising at least a first domain and a second domain selected from a constant Fc immunoglobulin domain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.